Tag: clinical trials

Make-vs-Buy Strategy & RFP Process Checklists for Clinical Operations and Vendor Governance Teams Make-vs-Buy Strategy & RFP Process Checklists for Clinical Operations and Vendor Governance Teams Introduction The clinical research industry is characterized by a need for agility, precision, and compliance. In navigating the complexities of clinical trials, organizations often face a crucial decision: whether…

Read More “Make-vs-Buy Strategy & RFP Process Checklists for Clinical Operations and Vendor Governance Teams” »

Common Pitfalls in Make-vs-Buy Strategy & RFP Process—and How to Avoid Regulatory Findings Common Pitfalls in Make-vs-Buy Strategy & RFP Process—and How to Avoid Regulatory Findings In the highly regulated landscape of clinical trials, the strategic choice between making an in-house solution or buying from an external vendor is paramount. The implications of this make-vs-buy…

Read More “Common Pitfalls in Make-vs-Buy Strategy & RFP Process—and How to Avoid Regulatory Findings” »

Using KPIs and SLAs to Optimize Make-vs-Buy Strategy & RFP Process Across CROs and Service Providers The decision-making process surrounding clinical trial execution often involves complex evaluations regarding whether to conduct certain activities in-house (make) or to outsource to Contract Research Organizations (CROs) and other service providers (buy). This make-vs-buy strategy is critical in the…

Read More “Using KPIs and SLAs to Optimize Make-vs-Buy Strategy & RFP Process Across CROs and Service Providers” »

Make-vs-Buy Strategy & RFP Process for Decentralized, Hybrid and Data-Heavy Clinical Trials In the evolving landscape of clinical trials, particularly as they become increasingly decentralized and data-heavy, clinical operations, regulatory affairs, and medical affairs professionals must navigate a critical choice: whether to make or buy the resources, technology, and expertise required to execute a successful…

Read More “Make-vs-Buy Strategy & RFP Process for Decentralized, Hybrid and Data-Heavy Clinical Trials” »

Make-vs-Buy Strategy & RFP Process: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs Make-vs-Buy Strategy & RFP Process: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs In the complex landscape of clinical trials, the decision to conduct studies in-house or outsource them presents a critical juncture. A well-structured Make-vs-Buy strategy and an effective Request for…

Read More “Make-vs-Buy Strategy & RFP Process: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs” »

How to Design Make-vs-Buy Strategy & RFP Process for Global GCP-Compliant Clinical Programs How to Design Make-vs-Buy Strategy & RFP Process for Global GCP-Compliant Clinical Programs In the complex landscape of clinical research, the decision to make or buy services essential for clinical trials is crucial. This comprehensive guide is aimed at clinical operations, regulatory…

Read More “How to Design Make-vs-Buy Strategy & RFP Process for Global GCP-Compliant Clinical Programs” »

Make-vs-Buy Strategy & RFP Process in Clinical Trials: Best Practices for US, UK and EU Markets Make-vs-Buy Strategy & RFP Process in Clinical Trials: Best Practices for US, UK and EU Markets In the realm of clinical trials, choosing between conducting studies in-house or outsourcing them to vendors is crucial to ensuring projects are completed…

Read More “Make-vs-Buy Strategy & RFP Process in Clinical Trials: Best Practices for US, UK and EU Markets” »

Risk-Based Make-vs-Buy Strategy & RFP Process: Reducing Cost Without Losing Quality or Control Risk-Based Make-vs-Buy Strategy & RFP Process: Reducing Cost Without Losing Quality or Control Understanding the Make-vs-Buy Decision in Clinical Trials The decision to make or buy services in the context of clinical trials is critical and often complex. This decision hinges on…

Read More “Risk-Based Make-vs-Buy Strategy & RFP Process: Reducing Cost Without Losing Quality or Control” »

Make-vs-Buy Strategy & RFP Process Strategies That Strengthen Vendor Oversight and Inspection Readiness The decision-making framework for outsourcing services in clinical trials often hinges on the strategic make-vs-buy evaluation. Understanding this process is essential for clinical operations, regulatory affairs, and medical affairs professionals who seek to optimize vendor oversight, ensure regulatory compliance, and prepare for…

Read More “Make-vs-Buy Strategy & RFP Process Strategies That Strengthen Vendor Oversight and Inspection Readiness” »